Brian R. Shy
0000-0001-9569-3708
Publication & Citation Trends
Publications
57 total
Ultra-large targeted DNA integrations in primary human cells
Cited by 0
Semantic Scholar
Preclinical development of an optimized manufacturing, CRISPR-edited, fully non-viral 1XX-enhanced anti-BCMA CAR-T therapy for multiple myeloma
Cited by 0
Semantic Scholar
CTIM-08. OPERATIONAL STRATEGIES AND REGULATORY NAVIGATION OF AN ACADEMIC CAR T-CELL TRIAL FOR GLIOBLASTOMA: EXPERIENCE FROM THE E-SYNC STUDY
Cited by 0
Semantic Scholar
Integrated epigenetic and genetic programming of primary human T cells.
Cited by 14
Semantic Scholar
247 UCCT-BCMA-1: a first-in-human, non-viral CRISPR-engineered CAR T cell therapy targeting BCMA in relapsed/refractory multiple myeloma
Cited by 0
Semantic Scholar
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci OA
Cited by 11
Semantic Scholar
Abstract PR008: CD4+ T cell rest and activation is enabled by centralized control of state specific regulatory genes
Cited by 0
Semantic Scholar
Research Topics
CRISPR and Genetic Engineering
(19)
CAR-T cell therapy research
(19)
T-cell and B-cell Immunology
(9)
SARS-CoV-2 and COVID-19 Research
(8)
Immune Cell Function and Interaction
(7)
Affiliations
Gladstone Institutes
City College of San Francisco
University of California, San Francisco
Wayne State University
University of Illinois Chicago